Global NK Cell Cytotoxicity Assay Service Market Growth (Status and Outlook) 2025-2031

The global NK Cell Cytotoxicity Assay Service market size is predicted to grow from US$ 291 million in 2025 to US$ 399 million in 2031; it is expected to grow at a CAGR of 5.4% from 2025 to 2031.

NK cell cytotoxicity assay service is a testing service designed to evaluate the functional activity of natural killer (NK) cells. It involves in vitro experiments to measure the cytotoxic effects of NK cells on target cells, such as tumor cells or virus-infected cells. This service is widely used in immunotherapy research, drug screening, and immune function assessment.

United States market for NK Cell Cytotoxicity Assay Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for NK Cell Cytotoxicity Assay Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for NK Cell Cytotoxicity Assay Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key NK Cell Cytotoxicity Assay Service players cover Agilent, Laboratories, Explicyte, Reaction Biology, Axion BioSystems, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “NK Cell Cytotoxicity Assay Service Industry Forecast” looks at past sales and reviews total world NK Cell Cytotoxicity Assay Service sales in 2024, providing a comprehensive analysis by region and market sector of projected NK Cell Cytotoxicity Assay Service sales for 2025 through 2031. With NK Cell Cytotoxicity Assay Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world NK Cell Cytotoxicity Assay Service industry.

This Insight Report provides a comprehensive analysis of the global NK Cell Cytotoxicity Assay Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on NK Cell Cytotoxicity Assay Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global NK Cell Cytotoxicity Assay Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for NK Cell Cytotoxicity Assay Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global NK Cell Cytotoxicity Assay Service.

This report presents a comprehensive overview, market shares, and growth opportunities of NK Cell Cytotoxicity Assay Service market by product type, application, key players and key regions and countries.

Segmentation by Type:
LDH (Lactate Dehydrogenase) Release Method
51Cr Release Method
Flow Cytometry Detection
Other

Segmentation by Application:
Cancer Research
Infectious Disease Research
Immunotherapy Development

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Agilent
Laboratories
Explicyte
Reaction Biology
Axion BioSystems
Sartorius
ICE Bioscience
Shanghai Saily Biotechnology
ProBio
Charles River
Imodels
Xeno Diagnostics
Cyagen
MarinBio
Pharmalegacy
Celentyx
Crown Bioscience
Cellomatics Biosciences

Please note: The report will take approximately 2 business days to prepare and deliver.